Dopamine efflux by MPTP and hydroxyl radical generation

Journal of Neural Transmission

Volumn 109, Issue 9, 2002, Pages 1159-1180

  Obata, T ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); 1 methyl 4 phenylpyridinium ion (MPP+); Dopamine; Free radicals; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3 DIHYDROXYBENZOIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CALCIUM; CARBIDOPA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FREE RADICAL; HYDROXYL RADICAL; MONOAMINE; NEUROMELANIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; POTASSIUM; REACTIVE OXYGEN METABOLITE; RESERPINE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOTRANSFORMATION; BRAIN; BRAIN INJURY; BRAIN MEMBRANE; BRAIN PERFUSION; CALCIUM METABOLISM; DEGENERATIVE DISEASE; DEPOLARIZATION; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATION; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DOPAMINE; HUMANS; HYDROXYL RADICAL; MPTP POISONING; NEOSTRIATUM; NITRIC OXIDE; OXIDATIVE STRESS; PRESYNAPTIC TERMINALS;

EID: 0036053197     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-001-0683-2     Document Type: Article

References (152)

1. Parkinson's disease: Pathophysiology
2. Huntington's chorea: Selective depletion of activity of angiotensin converting enzyme in the corpus striatum
3. Estrogen modulates responses of striatal dopamine neurons to MPP (+): Evaluations using in vitro and in vivo techniques
4. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
5. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite
6. Regulation of intracellular calcium compartmentation: Studies with isolated hepatocytes and t-butyl hydroperoxide
7. Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats
8. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
9. Subcellular localization and partial purification of a chloride dependent angiotensin-I converting enzyme from rat brain
10. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
11. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker
12. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation
13. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo
14. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
15. Oxygen free radical involvement in ischemia and reperfusion injury to brain
16. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia
17. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine
18. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
19. 2+: An alternate mechanism for the cardiotoxicity of doxorubicin
20. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography
21. + enhances potassium-evoked striatal dopamine release through a omega-conotoxin-insensitive, tetrodotoxin- and nimodipine-sensitive calcium-dependent mechanism
22. Enhanced hydroxyl radical generation by 2′-methyl analog of MPTP: Suppression by clorgyline and deprenyl
23. +
24. Hydroxyl free radical (·OH) formation reflected by salicylate hydroxylation and neuromelanin. In vivo markers for oxidant injury of nigral neurons
25. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism
26. Suppression of hydroxyl radical formation by MAO inhibitors: A novel possible neuroprotective mechanism in dopaminergic neurotoxicity
27. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia
28. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement
29. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents
30. Indoleamines and affective disorders
31. Nitric oxide and oxygen radicals: A question of balance
32. Indirect mutagenesis by oxidative DNA damage: Formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal
33. Basal lipid peroxidation in substantia nigra is increased in Parinson's disease
34. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity
35. Enhanced autooxidation of dopamine as a possible basis of manganese neurotoxicity
36. Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride
37. L-DOPA: Effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice
38. Long-lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats
39. Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo
40. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products
41. The apparent autooxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra
42. In vivo autoxidation of dopamine in guinea pig striatum increases with age
43. The metabolism of dopamine by both forms of monoamine oxidase in the brain and its inhibition by cimoxatone
44. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
45. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
46. Oxidative stress: Free radical production in neural degeneration
47. Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease
48. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards Cl300 neuroblastoma cells in vitro
49. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids
50. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine
51. Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: Is it a mechanism for hydroxyl radical production in biochemical systems?
52. Oxidants and the central nervous system: Some fundamental questions. Is oxidants damage relevant to Parkinson's disease, Altzheimer's disease, traumatic injury, or stroke?
53. Reactive oxygen species and the central nervous system
54. Hydroxylation of p-coumaric acid by horseradish peroxidase. The role of superoxide and hydroxyl radicals
55. Hydroxylation of salicylate as an assay for hydroxyl radicals: A cautionary note
56. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
57. +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
58. Rapid electrophysiological changes leading to arrhythmias in the aerobic rat heart. Photosensitization studies with rose bengal-derived reactive oxygen intermediates
59. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice
60. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
61. Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo?
62. Interactions of angiotensin II with central dopamine
63. Photodynamic action of merocyanine 540 on artificial and natural cell membranes: Involvement of singlet molecular oxygen
64. Detecting irradiated foods: Use of hydroxyl radical biomarkers
65. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
66. Brain dialysis: In vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats
67. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Relationship between the enzyme inhibition and the neurotoxicity
68. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its relevance to parkinson disease
69. The parkinsonian models: Invertebrates to mammals
70. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
71. Preservation of midbrain catecholaminergic neurons in very old human subjects
72. Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts
73. MPTP neurotoxicity: An overview and characterization of phases of toxicity
74. Systemic administration of D-amphetamine induced a delayed production of nitric oxide in the striatum of rats
75. The neurochemistry of Parkinson's disease: Effect of L-dopa therapy
76. Aromatic L-amino acid decarboxylase
77. The role of monoamine metabolism in oxidative glutamate toxicity
78. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
79. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide
80. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity
81. + on the release of serotonin and 5-hydroxyindole acetic acid from rat striatum in vivo
82. Neurochemical and neurogenetic correlates of Parkinson's disease
83. Cobalt (II) ion as a promoter of hydroxyl radical and possible 'crypto-hydroxyl' radical formation under physiological conditions. Differential effects of hydroxyl radical scavengers
84. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion
85. Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin
86. Molecular biology of catecholamine-related enzymes in relation to Parkinson's disease
87. Changes in cytokines and neurotrophins in Parkinson's disease
88. L-Dopa-induced release of cerebral monoamines
89. + in rat striatum
90. Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced ·OH generation in rat striatum
91. +
92. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation by monoamine oxidase inhibitor in the rat
93. Protective effect of carbidopa on hydroxyl radical generation in the rat striatum by dopamine
94. +-induced hydroxyl radical generation in rat striatum
95. Methamphetamine enhances 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in the rat striatum
96. Protective effect of histidine on potassium chloride depolarization enhances 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in the rat striatum
97. Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum
98. +-induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum
99. In vivo release of dopamine by perfusion of 1-methyl-4-phenylpyridinium ion in the striatum with a microdialysis technique
100. In vivo monitoring of norepinephrine and ·OH generation on myocardial ischemic injury by dialysis technique
101. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation by antidepressant drugs in the rat
102. +-induced hydroxyl radical generation in the rat striatum
103. +) into the striatum is associated with hydroxyl free radical generation
104. 2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture
105. Possible explanations for the antagonism by nicotine against reserpine-induced depletion of monoamines in mous brain
106. +) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a microdialysis technique
107. The effect of melanin on iron associated decomposition of hydrogen peroxide
108. The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals
109. Use of salicylate as a probe for ·OH formation in isolated ischemic rat hearts
110. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders
111. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
112. The potentiation of cardiodepressant and hypotensive effects of bradykinin by enalapril and captopril both in vitro and in vivo
113. Neuromelanin synthesis in rat and human substantia nigra
114. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
115. Determination of hydroxylated aromatic compounds produced via superoxide-dependent formation of hydroxyl radicals by liquid chromatography/electrochemistry
116. Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and antiestrogen drug tamoxifen
117. Superoxide-dependent formation of hydroxyl radicals: Detection of hydroxyl radicals by the hydroxylation of aromatic compounds
118. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
119. Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease
120. +-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis
121. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro
122. +) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons
123. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats
124. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon
125. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases
126. Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms
127. ESR spin trapping investigation on peroxynitrite decomposition: No evidence for hydroxyl radical production
128. +): Reductive activation by NADPH cytochrome P-450 reductase
129. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: An electron paramagnetic resonance spectroscopy study
130. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases
131. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases
132. MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture
133. The effects of L-dopa on in vitro dopamine release from striatum
134. Dopamine turnover and glutathione oxidation: Implications for Parkinson's disease
135. +
136. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
137. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells
138. Inhibition of depolarization-induced nitric oxide synthase activation by NS-7, a phenylpyrimidine derivative, in primary neuronal culture
139. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis
140. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
141. Experimental biology of cerebral hypoxia-ischemia: Relation to perinatal brain damage
142. Myocardial protection by R 56865: A new principle based on prevention of ion channel pathology
143. Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture
144. Loss of transforming activity of plasmid DNA (pBR322) in E. coli caused by singlet molecular oxygen
145. The structural mimicry of membrane sterols by tamoxifen: Evidence from cholesterol coefficients and molecular-modelling for its action as a membrane anti-oxidant and an anti-cancer agent
146. + in vivo
147. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
148. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
149. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
150. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
151. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: Consequences for iron storage and neurodegenerative processes
152. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy